Trials / Completed
CompletedNCT00520962
Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,997 (actual)
- Sponsor
- IRCCS San Raffaele · Academic / Other
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis. The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be \> 30 years, both gender.
Detailed description
The primary outcome of the study is evaluation of glucose tolerance, insulin sensitivity and insulin secretion before and 2 hours post-glucose load Secondary outcomes are evaluation of endothelial function, of natriuretic peptides and free fatty acids, and inflammation before and 2 hours post-glucose load. New candidate genes will be also evaluated.
Conditions
Timeline
- Start date
- 1997-06-01
- Completion
- 2006-05-01
- First posted
- 2007-08-27
- Last updated
- 2007-08-27
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00520962. Inclusion in this directory is not an endorsement.